Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.
Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.
复制标题
DOI:
10.3389/fimmu.2017.01829
复制
发表时间:
2017
影响因子:
7.3
通讯作者:
Cerundolo V
中科院分区:
文献类型:
--
作者:
Bedard M;Salio M;Cerundolo V
Invariant natural killer T (iNKT) cells are a distinct subset of innate-like lymphocytes bearing an invariant T-cell receptor, through which they recognize lipid antigens presented by monomorphic CD1d molecules. Upon activation, iNKT cells are capable of not only having a direct effector function but also transactivating NK cells, maturing dendritic cells, and activating B cells, through secretion of several cytokines and cognate TCR-CD1d interaction. Endowed with the ability to orchestrate an all-encompassing immune response, iNKT cells are critical in shaping immune responses against pathogens and cancer cells. In this review, we examine the critical role of iNKT cells in antitumor responses from two perspectives: (i) how iNKT cells potentiate antitumor immunity and (ii) how CD1d+ tumor cells may modulate their own expression of CD1d molecules. We further explore hypotheses to explain iNKT cell activation in the context of cancer and how the antitumor effects of iNKT cells can be exploited in different forms of cancer immunotherapy, including their role in the development of cancer vaccines.
登录
查看更多内容
影响因子:
30.5
作者:
Beyaz S;Kim JH;Pinello L;Xifaras ME;Hu Y;Huang J;Kerenyi MA;Das PP;Barnitz RA;Herault A;Dogum R;Haining WN;Yilmaz ÖH;Passegue E;Yuan GC;Orkin SH;Winau F
通讯作者:
Winau F
影响因子:
30.5
作者:
通讯作者:
--
影响因子:
3.4
作者:
Chong TW;Goh FY;Sim MY;Huang HH;Thike AA;Lim WK;Teh BT;Tan PH
通讯作者:
Tan PH
影响因子:
5.8
作者:
Carreño LJ;Saavedra-Ávila NA;Porcelli SA
通讯作者:
Porcelli SA
影响因子:
30.5
作者:
Brennan, Patrick J.;Tatituri, Raju V. V.;Brigl, Manfred;Kim, Edy Y.;Tuli, Amit;Sanderson, Joseph P.;Gadola, Stephan D.;Hsu, Fong-Fu;Besra, Gurdyal S.;Brenner, Michael B.
通讯作者:
Brenner, Michael B.